Skip to main content
. 2020 Sep 16;10(9):208. doi: 10.3390/life10090208

Table 2.

Clinical trials on going.

Phase Protocol Cancer Species Reference
I/II pembrolizumab plus D + T BRAF-mutated advanced melanoma NCT02130466
I pembrolizumab plus V + C BRAF-mutated advanced melanoma NCT02818023
II sequential V + C and N + I BRAF-mutated advanced melanoma NCT02968303
II neoadjuvant N + I macroscopic stage III melanoma [89]
II anti-PD1 Abs plus denosumab stage III/IV melanoma NCT03620019
III vorinostat plus BRAFi/MEKi resistant BRAFV600E mutant melanoma NCT02836548